Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

被引：0
|
作者：
Nakamura, Minoru
Kondo, Hisayoshi
Mori, Tsuyoshi
Komori, Atsumasa
Matsuyama, Mutsumi
Ito, Masahiro
Daikoku, Manabu
Yatsuhashi, Hiroshi
Takezaki, Eiichi
Masaki, Naohiko
Sugi, Kazuhiro
Adachi, Hiroshi
Sakai, Norihiro
Watanabe, Yukio
Saoshiro, Takeo
Honda, Koichi
Harada, Hideharu
Hayashi, Shigeki
Sando, Takehiro
Masumoto, Akihide
Shimada, Masaaki
Komatsu, Tatsuji
Shums, Zakera
Norman, Gary L.
Ishibashi, Hiromi
机构：
[1] Natl NHO Nagasaki Med Ctr, Clin Res Ctr, Omura, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hepatol, Omura, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Nagasaki 852, Japan
[4] NHO Study Grp Liver Dis Japan, Omura, Japan
[5] INOVA Diagnost, San Diego, CA USA
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1180
引用
收藏
页码：629A / 629A
页数：1
相关论文
共 50 条
  • [41] ANTI-CENTROMERE ANTIBODY ISOTYPE LEVELS AS BIOMARKER FOR DISEASE PROGRESSION IN SUBJECTS AT RISK TO DEVELOP SYSTEMIC SCLEROSIS
    Van Leeuwen, N.
    Bakker, J.
    Grummels, A.
    Wortel, C.
    Jordan, S.
    Liem, S.
    Distler, O.
    Hoffmann-Vold, A. M.
    Melsens, K.
    Smith, V.
    Truchetet, M. E.
    Scherer, H. U.
    Toes, R.
    Huizinga, T.
    De Vries-Bouwstra, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1096 - 1096
  • [42] EVIDENCE OF DIFFERENT SUBTYPES OF ANTI-MITOCHONDRIAL ANTIBODIES IN PRIMARY BILIARY-CIRRHOSIS USING RADIOIMMUNOASSAYS
    MANNS, M
    GERKEN, G
    PORALLA, T
    STARITZ, M
    ZUMBUSCHENFELDE, KHM
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1985, 23 (09): : 481 - 481
  • [43] GP210 AND/OR SP100 ANTIBODIES IN PRIMARY BILIARY CIRRHOSIS: PREDICTORS OF CIRRHOSIS/AUTOIMMUNE (AIH) OVERLAP SYNDROMES?
    Taiwo, O.
    Mathew, S.
    Van Vlymen, J.
    Correa, A.
    Deacock, S. J.
    Berry, P.
    Cheent, K.
    Lewis, H.
    Ala, A.
    GUT, 2015, 64 : A263 - A263
  • [44] The diagnostic value of anti-mitochondrial antibodies, especially in primary biliary cirrhosis
    Tanaka, A
    Miyakawa, H
    Luketic, VAC
    Kaplan, M
    Storch, WB
    Gershwin, ME
    CELLULAR AND MOLECULAR BIOLOGY, 2002, 48 (03) : 295 - 299
  • [45] Anti-mitochondrial antibodies and other immunological tests in primary biliary cirrhosis
    Strassburg, CP
    Jaeckel, E
    Manns, MP
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1999, 11 (06) : 595 - 601
  • [46] Anti-eosinophil peroxidase antibodies detected in patients with primary biliary cirrhosis
    Takiguchi, J
    Ohira, H
    Rai, T
    Abe, K
    Takahashi, A
    Sato, Y
    HEPATOLOGY RESEARCH, 2005, 32 (01) : 33 - 37
  • [47] Impact of double positive for anti-centromere and anti-SS-a/Ro antibodies on clinicopathological characteristics of primary Sjogren's syndrome: a retrospective cohort study
    Suzuki, Yasunori
    Fujii, Hiroshi
    Nomura, Hideki
    Mizushima, Ichiro
    Yamada, Kazunori
    Yamagishi, Masakazu
    Kawano, Mitsuhiro
    MODERN RHEUMATOLOGY, 2018, 28 (05) : 872 - 878
  • [48] Anti-idiotypic antibodies to anti-PDC-E3 in primary biliary cirrhosis and normal subjects
    Chen, QY
    Rowley, MJ
    Mackay, IR
    HEPATOLOGY, 1999, 29 (03) : 624 - 631
  • [49] Biliary Apotopes and Anti-Mitochondrial Antibodies Activate Innate Immune Responses in Primary Biliary Cirrhosis
    Lleo, Ana
    Bowlus, Christopher L.
    Yang, Guo-Xiang
    Invernizzi, Pietro
    Podda, Mauro
    Van de Water, Judy
    Ansari, Aftab A.
    Coppel, Ross L.
    Worman, Howard J.
    Gores, Gregory J.
    Gershwin, M. Eric
    HEPATOLOGY, 2010, 52 (03) : 987 - 998
  • [50] Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms
    Wang, Xiaoyi
    Yang, Zhen
    Ran, Ying
    Li, Long
    Wang, Bangmao
    Zhou, Lu
    ANNALS OF HEPATOLOGY, 2023, 28 (05)
12345